Skip to main content

Common patenting tactic by drug companies may be illegal, FTC says

By The New York Times  
   September 14, 2023

Experts say the exploitation of a loophole in the patent system has contributed to high prices for inhalers.

Full story

Get the latest on healthcare leadership in your inbox.